Asiatic acid inhibits rheumatoid arthritis fibroblast‐like synoviocyte growth through the Nrf2/HO‐1/NF‐κB signaling pathway.
Published In: Chemical Biology & Drug Design, 2024, v. 103, n. 3. P. 1 1 of 3
Database: Academic Search Ultimate 2 of 3
Authored By: Zhang, Li; Liu, Zhi‐ning; Han, Xi‐yuan; Liu, Xin; Li, Yang 3 of 3
Abstract
Asiatic acid (AA) is generally recognized in the treatment of various diseases and has significant advantages in the treatment of various inflammatory diseases. The treatment of rheumatoid arthritis (RA) with AA is a completely new entry point. RA is a complex autoimmune inflammatory disease, and despite the involvement of different immune and nonimmune cells in the pathogenesis of RA, fibroblast‐like synoviocytes (FLS) play a crucial role in the progression of the disease. si‐Nrf2 was transfected in RA‐FLS and the cells were treated with AA. MTT assay and colony formation assay were used to detect the effect of AA on the viability and formation of clones of RA‐FLS, respectively. Moreover, the apoptosis of RA‐FLS was observed by Hoechst 33342 staining and flow cytometry. Western blot was applied to measure the expression of the Nrf2/HO‐1/NF‐κB signaling pathway‐related proteins. Compared with the control group, RA‐FLS proliferation, and clone formation were significantly inhibited by the increase of AA concentration, and further experiments showed that AA‐induced apoptosis of RA‐FLS. In addition, AA activated the Nrf2/HO‐1 pathway to inhibit NF‐κB protein expression. However, the knockdown of Nrf2 significantly offsets the effects of AA on the proliferation, apoptosis, and Nrf2/HO‐1/NF‐κB signaling pathway of RA‐FLS cells. AA can treat RA by inhibiting the proliferation and inducing the apoptosis of RA‐FLS. The mechanism may be related to the activation of the Nrf2/HO‐1/NF‐κB pathway. [ABSTRACT FROM AUTHOR]
Additional Information
- Source:Chemical Biology & Drug Design. 2024/03, Vol. 103, Issue 3, p1
- Document Type:Article
- Subject Area:Complementary and Alternative Medicine
- Publication Date:2024
- ISSN:1747-0277
- DOI:10.1111/cbdd.14454
- Accession Number:176295116
- Copyright Statement:Copyright of Chemical Biology & Drug Design is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Looking to go deeper into this topic? Look for more articles on EBSCOhost.